Magnetization transfer ratio may be a surrogate of spongiform change in human prion diseases

Brain

Volumn 133, Issue 10, 2010, Pages 3058-3068

  Siddique, Durrenajaf ^a,b   Hyare, Harpreet ^a,b   Wroe, Stephen ^a,b   Webb, Thomas ^a,b   MacFarlane, Rebecca ^a,b   Rudge, Peter ^a,b   Collinge, John ^a,b   Powell, Caroline ^b   Brandner, Sebastian ^a,b   So, Po Wah ^c   Walker, Sarah ^d   Mead, Simon ^a,b   Yousry, Tarek ^a   Thornton, John S ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

magnetization transfer; prion

Indexed keywords

PRION PROTEIN;

ADULT; AGED; ARTICLE; ASTROCYTOSIS; AUTOPSY; BRAIN SPONGIOSIS; CAUDATE NUCLEUS; CEREBRAL MAGNETIZATION TRANSFER RATIO; CINGULATE GYRUS; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; CORRELATIONAL STUDY; CREUTZFELDT JAKOB DISEASE; DISEASE MARKER; DISEASE SEVERITY; FEMALE; FOLLOW UP; FRONTAL CORTEX; GENE MUTATION; GLIOSIS; GRAY MATTER; HEMISPHERE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INSULA; MALE; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL CORTEX; PARIETAL LOBE; PRION DISEASE; PRIORITY JOURNAL; PUTAMEN; RATING SCALE; TEMPORAL CORTEX; THALAMUS; WHITE MATTER; BRAIN; IMAGE PROCESSING; MIDDLE AGED; MYELINATED NERVE; NEUROPSYCHOLOGICAL TEST; NONPARAMETRIC TEST; PATHOLOGY; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX;

ADULT; BRAIN; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVE FIBERS, MYELINATED; NEUROPSYCHOLOGICAL TESTS; PRION DISEASES; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 77957683312     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awq243     Document Type: Article

References (39)

1. Barker GJ, Schreiber WG, Gass A, Ranjeva JP, Campi A, van Waesberghe JH, et al. A standardised method for measuring magnetisation transfer ratio on MR imagers from different manufacturers-the EuroMT sequence. MAGMA 2005; 18: 76-80.
2. Barker GJ, Tofts PS, Gass A. An interleaved sequence for accurate and reproducible clinical measurement of magnetization transfer ratio. Magn Reson Imaging 1996; 14: 403-11.
3. Bozzali M, Franceschi M, Falini A, Pontesilli S, Cercignani M, Magnani G, et al. Quantification of tissue damage in AD using diffusion tensor and magnetization transfer MRI. Neurology 2001; 57: 1135-7.
4. Collie DA, Summers DM, Sellar RJ, Ironside JW, Cooper S, Zeidler M, et al. Diagnosing variant Creutzfeldt-Jakob disease with the pulvinar sign: MR imaging findings in 86 neuropathologically confirmed cases. AJNR Am J Neuroradiol 2003; 24: 1560-9.
5. Collin C, Wade DT, Davies S, Horne V. The Barthel ADL Index: a reliability study. Int Disabil Stud 1988; 10: 61-3.
6. Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 2001; 24: 519-50.
7. Collinge J, Gorham M, Hudson F, Kennedy A, Keogh G, Pal S, et al. Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial. Lancet Neurol 2009; 8: 334-44.
8. Collinge J, Sidle KC, Meads J, Ironside J, Hill AF. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 1996; 383: 685-90.
9. Collinge J, Whitfield J, McKintosh E, Beck J, Mead S, Thomas DJ, et al. Kuru in the 21st century-an acquired human prion disease with very long incubation periods. Lancet 2006; 367: 2068-74.
10. Davies GR, Altmann DR, Hadjiprocopis A, Rashid W, Chard DT, Griffin CM, et al. Increasing normal-appearing grey and white matter magnetisation transfer ratio abnormality in early relapsing-remitting multiple sclerosis. J Neurol 2005; 252: 1037-44.
11. Dehmeshki J, Chard DT, Leary SM, Watt HC, Silver NC, Tofts PS, et al. The normal appearing grey matter in primary progressive multiple sclerosis: a magnetisation transfer imaging study. J Neurol 2003; 250: 67-74.
12. Filippi M, Rocca MA, Comi G. The use of quantitative magnetic-resonance- based techniques to monitor the evolution of multiple sclerosis. Lancet Neurol 2003; 2: 337-46.
13. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
14. Gallo A, Rovaris M, Benedetti B, Sormani MP, Riva R, Ghezzi A, et al. A brain magnetization transfer MRI study with a clinical follow up of about four years in patients with clinically isolated syndromes suggestive of multiple sclerosis. J Neurol 2007; 254: 78-83.
15. Guy W. Clinical global impressions (CGI). ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: US Department of Heath, Education, and Welfare Public Health Service Alcohol, Drug Abuse, and Mental Health Administration; 1976. p. 218-22.
16. Hill AF, Collinge J. Subclinical prion infection in humans and animals. Brit Med Bulletin 2003; 66: 161-70.
17. Kalus P, Slotboom J, Gallinat J, Wiest R, Ozdoba C, Federspiel A, et al. The amygdala in schizophrenia: a trimodal magnetic resonance imaging study. Neurosci Lett 2005; 375: 151-6.
18. Llewelyn CA, Hewitt PE, Knight RS, Amar K, Cousens S, Mackenzie J, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004; 363: 417-21.
19. Mallucci G, Dickinson A, Linehan J, Klohn P, Brandner S, Collinge J. Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 2003; 302: 871-4.
20. Mallucci G, White MD, Farmer M, Dickinson A, Khatun H, Powell AD, et al. Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice. Neuron 2007; 53: 325-35.
21. Matsusue E, Kinoshita T, Sugihara S, Fujii S, Ogawa T, Ohama E. White matter lesions in panencephalopathic type of Creutzfeldt-Jakob disease: MR imaging and pathologic correlations. AJNR Am J Neuroradiol 2004; 25: 910-8.
22. Morris JC. Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int Psychogeriatr 1997; 9 (Suppl 1): 173-6.
23. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep 1962; 10: 799-812.
24. Rankin J. Cerebral vascular accidents in patients over the age of 60. Scott Med J 1957; 2: 127-36.
25. Ridha BH, Symms MR, Tozer DJ, Stockton KC, Frost C, Siddique MM, et al. Magnetization transfer ratio in Alzheimer disease: comparison with volumetric measurements. AJNR Am J Neuroradiol 2007a; 28: 965-70.
26. Ridha BH, Tozer DJ, Symms MR, Stockton KC, Lewis EB, Siddique MM, et al. Quantitative magnetization transfer imaging in Alzheimer disease. Radiology 2007b; 244: 832-7.
27. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry 1984; 141: 1356-64.
28. Rovaris M, Judica E, Sastre-Garriga J, Rovira A, Sormani MP, Benedetti B, et al. Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis. Mult Scler 2008; 14: 455-64.
29. Schmierer K, Scaravilli F, Altmann DR, Barker GJ, Miller DH. Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Ann Neurol 2004; 56: 407-15.
30. Schmierer K, Wheeler-Kingshott CA, Tozer DJ, Boulby PA, Parkes HG, Yousry TA, et al. Quantitative magnetic resonance of postmortem multiple sclerosis brain before and after fixation. Magn Reson Med 2008; 59: 268-77.
31. Symms M, Jager HR, Schmierer K, Yousry TA. A review of structural magnetic resonance neuroimaging. J Neurol Neurosurg Psychiatry 2004; 75: 1235-44.
32. Tanaka Y, Hanyu H, Sakurai H, Shimizu S, Takasaki M. Characteristics of MRI features in Alzheimer's disease patients predicting response to donepezil treatment. Nippon Ronen Igakkai Zasshi 2003; 40: 261-6.
33. Tofts PS, Jackson JS, Tozer DJ, Cercignani M, Keir G, MacManus DG, et al. Imaging cadavers: cold FLAIR and noninvasive brain thermom-etry using CSF diffusion. Magn Reson Med 2008; 59: 190-5.
34. Tofts PS, Steens SC, Cercignani M, Admiraal-Behloul F, Hofman PA, van Osch MJ, et al. Sources of variation in multi-centre brain MTR histogram studies: body-coil transmission eliminates inter-centre differences. MAGMA 2006; 19: 209-22.
35. van der Flier WM, van den Heuvel DM, Weverling-Rijnsburger AW, Bollen EL, Westendorp RG, van Buchem MA, et al. Magnetization transfer imaging in normal aging, mild cognitive impairment, and Alzheimer's disease. Ann Neurol 2002; 52: 62-7.
36. van Waesberghe JH, Kamphorst W, De Groot CJ, van Walderveen MA, Castelijns JA, Ravid R, et al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 1999; 46: 747-54.
37. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996; 347: 921-5.
38. Wroe SJ, Pal S, Siddique D, Hyare H, Macfarlane R, Joiner S, et al. Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet 2006; 368: 2061-7.
39. Young GS, Geschwind MD, Fischbein NJ, Martindale JL, Henry RG, Liu S, et al. Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol 2005; 26: 1551-62.